DTC vs HRTX
DTC (DTC) versus Heron Therapeuti (HRTX) — a side-by-side from cached financials, not a winner call.
DTC (DTC) common stock.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
DTC does not have a complete income-statement cache yet.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
HRTX currently screens at market cap $332.6M.
Not investment advice. Open the DTC and HRTX stock pages for the full models.
Not investment advice.